Ivory, an early-stage brain health startup, has raised $1 million in a funding round co-led by IIM-A Ventures and Capital-A. The round also saw participation from 1Crowd, and Stanford Angels, along with angel investors such as Dr Sanjay Arora, Adarsh Narahari and Juhi Bhatnagar.
The fresh funds raised will be used to strengthen its technology for its clinical grade assessments and scale distribution to reach more individuals across India. Ivory also plans to expand its footprint across new geographies, deepen AI capabilities to personalise assessments further, and invest in longitudinal research to build benchmarks for cognitive health specific to Indian populations.
Rahul Krishnan, Co-founder and CPO, Ivory, said, “With this capital, we aim to further invest in our technology—enhancing the accuracy, depth and reach of our cognitive assessments. As conversations around longevity and preventive health gain momentum, Ivory stands at the intersection of technology, healthcare and ageing to reshape how we approach long-term brain wellness.”
Issac John, Co-Founder and CEO, said, “At Ivory, we are building for a future where brain health is prioritized just like physical health. As people move into their 40s and beyond, Ivory’s early detection and intervention-led approach towards cognitive risks will play a pivotal role in reducing society’s healthcare burden.”
Vipul Patel, Partner, IIM-A Ventures, said, “Of the four horsemen of chronic illness, neurodegenerative diseases remain the least understood and most difficult to reverse. Ivory’s vision to bring early, accessible cognitive screening into everyday preventive health is both timely and essential. Ivory’s ability to marry clinical depth with an engaging consumer experience is commendable, which is also something this space has lacked. As Medicine 3.0 shifts focus from reactive treatment to proactive prevention, we believe Ivory can define how cognitive care fits into everyday health decisions.”
Ankit Kedia, Founder & Lead Investor, Capital-A, said, “There is a growing awareness that brain health is a core pillar of preventive care and yet solutions remain limited. Ivory is bringing a data-led, clinically grounded platform to the table, and we believe their work will play a crucial role in shaping the future of ageing and mental wellness.”
Founded in 2022 by Issac John and Rahul Krishnan, Ivory focuses on the early detection of cognitive decline through digital assessments based on neuroscience. Ivory is bringing a data-led, clinically grounded platform to the table that could reshape the future of aging and mental wellness.
The Bengaluru-based startup offers two core products, targeting people in their 30s and above. The first is an assessment tool that helps users gain insights into their cognitive profile—highlighting strengths, weaknesses, and signs of accelerated neurodegeneration.
The second product is a subscription-based daily companion app that promotes cognitive well-being through routine brain training exercises, while also helping users track their overall health and wellness.
Beyond its consumer app, Ivory has built strategic partnerships with companies like Ather Energy, WeWork, and Puma to offer workplace cognitive risk screenings. The startup recently released Brain Health Report and gained national recognition after appearing on Shark Tank India Season 4.
